FAKTOR OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - BOERSE MUENCHEN 01:16:35 01/06/2024 am IST | ||
| 22.67 EUR | -7.24% |
|
| 1 month | +38.15% | ||
| 3 months | +124.46% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 22.67 | -7.24% |
| 30/24/30 | 24.44 | +0.53% |
| 29/24/29 | 24.31 | +0.87% |
| 28/24/28 | 24.1 | +13.36% |
| 27/24/27 | 21.26 | -3.76% |
Real-time BOERSE MUENCHEN
Last update May 01, 2024 at 01:16 am IST
More quotesStatic data
| Product type | Exotische Produkte |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
UniCredit
|
| WKN | HD36D6 |
| ISIN | DE000HD36D60 |
| Date issued | 28/02/2024 |
| Strike | 48.3 $ |
| Maturity | Unlimited |
| Parity | 0.31 : 1 |
| Emission price | 10.53 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 25.52 € |
|---|---|
| Lowest since issue | 6.73 € |
| Spread | 0.05 € |
| Spread % | 0.23% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.09
USD
Average target price
53.19
USD
Spread / Average Target
+29.46%
- Stock Market
- Certificates
- Certificat
